Yoran M Leter

This study investigates how CSF1R inhibition during cranial radiotherapy affects the brain's immune environment and glial dynamics, showing sustained microglial loss and monocyte replacement.

This study shows that high-dose CSF1R inhibitors pexidartinib and sotuletinib rapidly deplete microglia despite limited brain penetration, with significant off-target effects on other immune and tissue cells.